Effects of Neoadjuvant Intraperitoneal/Systemic Chemotherapy (Bidirectional Chemotherapy) for the Treatment of Patients with Peritoneal Metastasis from Gastric Cancer

Table 6

Pathological response after NIPS.

	Responder
Ef-0	Ef-1	Ef-2	Ef-3
Primary tumor	11 (13.4%)	43 (52.5%)	28 (34.1%)	0 (0%)
PC	25 (30.4%)	20 (24.3%)	7 (8.5%)	30 (36.8%)